Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

ASSOCIATION OF BASELINE CORTICOSTEROID WITH OUTCOMES IN A MULTIVARIATE ANALYSIS OF THE PHASE 3 AFFIRM STUDY OF ENZALUTAMIDE (ENZA), AN ANDROGEN RECEPTOR SIGNALING INHIBITOR (ARSI)

Publication ,  Conference
Scher, HI; Fizazi, K; Saad, F; Chi, K; Taplin, M; Sternberg, CN; Armstrong, AJ; Hirmand, M; Selby, B; de Bono, JS
Published in: ANNALS OF ONCOLOGY
September 1, 2012

Duke Scholars

Published In

ANNALS OF ONCOLOGY

ISSN

0923-7534

Publication Date

September 1, 2012

Volume

23

Start / End Page

297 / 297

Location

Vienna, AUSTRIA

Publisher

OXFORD UNIV PRESS

Conference Name

37th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Scher, H. I., Fizazi, K., Saad, F., Chi, K., Taplin, M., Sternberg, C. N., … de Bono, J. S. (2012). ASSOCIATION OF BASELINE CORTICOSTEROID WITH OUTCOMES IN A MULTIVARIATE ANALYSIS OF THE PHASE 3 AFFIRM STUDY OF ENZALUTAMIDE (ENZA), AN ANDROGEN RECEPTOR SIGNALING INHIBITOR (ARSI). In ANNALS OF ONCOLOGY (Vol. 23, pp. 297–297). Vienna, AUSTRIA: OXFORD UNIV PRESS.
Scher, H. I., K. Fizazi, F. Saad, K. Chi, M. Taplin, C. N. Sternberg, A. J. Armstrong, M. Hirmand, B. Selby, and J. S. de Bono. “ASSOCIATION OF BASELINE CORTICOSTEROID WITH OUTCOMES IN A MULTIVARIATE ANALYSIS OF THE PHASE 3 AFFIRM STUDY OF ENZALUTAMIDE (ENZA), AN ANDROGEN RECEPTOR SIGNALING INHIBITOR (ARSI).” In ANNALS OF ONCOLOGY, 23:297–297. OXFORD UNIV PRESS, 2012.
Scher HI, Fizazi K, Saad F, Chi K, Taplin M, Sternberg CN, et al. ASSOCIATION OF BASELINE CORTICOSTEROID WITH OUTCOMES IN A MULTIVARIATE ANALYSIS OF THE PHASE 3 AFFIRM STUDY OF ENZALUTAMIDE (ENZA), AN ANDROGEN RECEPTOR SIGNALING INHIBITOR (ARSI). In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2012. p. 297–297.
Scher HI, Fizazi K, Saad F, Chi K, Taplin M, Sternberg CN, Armstrong AJ, Hirmand M, Selby B, de Bono JS. ASSOCIATION OF BASELINE CORTICOSTEROID WITH OUTCOMES IN A MULTIVARIATE ANALYSIS OF THE PHASE 3 AFFIRM STUDY OF ENZALUTAMIDE (ENZA), AN ANDROGEN RECEPTOR SIGNALING INHIBITOR (ARSI). ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2012. p. 297–297.
Journal cover image

Published In

ANNALS OF ONCOLOGY

ISSN

0923-7534

Publication Date

September 1, 2012

Volume

23

Start / End Page

297 / 297

Location

Vienna, AUSTRIA

Publisher

OXFORD UNIV PRESS

Conference Name

37th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis